Pulmonary MR Angiography and Lower Extremity MR Venous Imaging Using Gadofosveset (Ablavar)

• Status: Completed
• Trial end date: 2013-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The use of the contrast agent, Ablavar, will help with the diagnosis of pulmonary embolism in magnetic resonance imaging (MRI).

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Washington University School of Medicine
• Collaborator: Lantheus Medical Imaging

Criteria

Inclusion Criteria:

1. Patient that have pulmonary embolism.

2. 18 yrs of age and older

Exclusion Criteria:

1. allergy to gadolinium based contrast.

2. allergy to iodated based contrast.

3. renal insufficiency (GFR < 60 mL/min?1.73m2)

4. pregnant or nursing

5. contraindication to MRI